Keay Nakae
Stock Analyst at Chardan Capital
(4.45)
# 313
Out of 5,051 analysts
254
Total ratings
46.77%
Success rate
26.43%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRQR ProQR Therapeutics | Maintains: Buy | $4 | $2.37 | +68.78% | 16 | Nov 4, 2025 | |
| RNA Avidity Biosciences | Downgrades: Neutral | $75 → $72 | $69.83 | +3.11% | 20 | Oct 28, 2025 | |
| MNPR Monopar Therapeutics | Maintains: Buy | $60 → $85 | $82.38 | +3.18% | 4 | Sep 25, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $12 | $3.22 | +272.67% | 17 | Sep 19, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $14 | $5.81 | +140.96% | 21 | Sep 17, 2025 | |
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $3.90 | +412.82% | 12 | Aug 13, 2025 | |
| KRRO Korro Bio | Maintains: Buy | $25 | $33.28 | -24.87% | 3 | Aug 13, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $40.00 | +50.00% | 20 | Aug 11, 2025 | |
| ABUS Arbutus Biopharma | Maintains: Buy | $5 | $4.39 | +13.90% | 13 | Aug 11, 2025 | |
| SLN Silence Therapeutics | Maintains: Buy | $35 | $6.02 | +481.40% | 13 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $400 | $436.95 | -8.46% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $38 | $21.19 | +79.33% | 13 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $1.50 | +233.33% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1.25 → $6 | $13.05 | -54.02% | 10 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 | $4.03 | +396.89% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.75 | +242.86% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.5 | $1.68 | +48.81% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.76 | +951.39% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.75 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $15.64 | -61.62% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $20 | $0.40 | +4,883.80% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $10.16 | +441.34% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $4.24 | +135.63% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $10.92 | +701.28% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $1.44 | +802.78% | 3 | Feb 9, 2021 |
ProQR Therapeutics
Nov 4, 2025
Maintains: Buy
Price Target: $4
Current: $2.37
Upside: +68.78%
Avidity Biosciences
Oct 28, 2025
Downgrades: Neutral
Price Target: $75 → $72
Current: $69.83
Upside: +3.11%
Monopar Therapeutics
Sep 25, 2025
Maintains: Buy
Price Target: $60 → $85
Current: $82.38
Upside: +3.18%
SAB Biotherapeutics
Sep 19, 2025
Maintains: Buy
Price Target: $12
Current: $3.22
Upside: +272.67%
Coya Therapeutics
Sep 17, 2025
Maintains: Buy
Price Target: $14
Current: $5.81
Upside: +140.96%
Orchestra BioMed Holdings
Aug 13, 2025
Maintains: Buy
Price Target: $20
Current: $3.90
Upside: +412.82%
Korro Bio
Aug 13, 2025
Maintains: Buy
Price Target: $25
Current: $33.28
Upside: -24.87%
Arrowhead Pharmaceuticals
Aug 11, 2025
Maintains: Buy
Price Target: $60
Current: $40.00
Upside: +50.00%
Arbutus Biopharma
Aug 11, 2025
Maintains: Buy
Price Target: $5
Current: $4.39
Upside: +13.90%
Silence Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $35
Current: $6.02
Upside: +481.40%
Aug 1, 2025
Maintains: Buy
Price Target: $325 → $400
Current: $436.95
Upside: -8.46%
Jul 29, 2025
Maintains: Buy
Price Target: $50 → $38
Current: $21.19
Upside: +79.33%
Jun 25, 2025
Maintains: Buy
Price Target: $5
Current: $1.50
Upside: +233.33%
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $13.05
Upside: -54.02%
Apr 7, 2025
Maintains: Buy
Price Target: $20
Current: $4.03
Upside: +396.89%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $1.75
Upside: +242.86%
Mar 27, 2025
Maintains: Neutral
Price Target: $2.5
Current: $1.68
Upside: +48.81%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.76
Upside: +951.39%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.75
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $15.64
Upside: -61.62%
Nov 10, 2022
Maintains: Buy
Price Target: $60 → $20
Current: $0.40
Upside: +4,883.80%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $10.16
Upside: +441.34%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $4.24
Upside: +135.63%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $10.92
Upside: +701.28%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $1.44
Upside: +802.78%